503 related articles for article (PubMed ID: 26823742)
21. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
22. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
[TBL] [Abstract][Full Text] [Related]
23. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
24. The role of Reg IV gene and its encoding product in gastric carcinogenesis.
Zheng HC; Xu XY; Yu M; Takahashi H; Masuda S; Takano Y
Hum Pathol; 2010 Jan; 41(1):59-69. PubMed ID: 19740514
[TBL] [Abstract][Full Text] [Related]
25. [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].
Liu WT; Jiao HL; Yang YL; Wang D; Zhang WM
Ai Zheng; 2007 Nov; 26(11):1199-203. PubMed ID: 17991318
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.
Kim TY; Jong HS; Song SH; Dimtchev A; Jeong SJ; Lee JW; Kim TY; Kim NK; Jung M; Bang YJ
Oncogene; 2003 Jun; 22(25):3943-51. PubMed ID: 12813468
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
[TBL] [Abstract][Full Text] [Related]
28. Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway.
Li X; Liang Q; Liu W; Zhang N; Xu L; Zhang X; Zhang J; Sung JJ; Yu J
Oncogene; 2016 May; 35(19):2453-64. PubMed ID: 26279301
[TBL] [Abstract][Full Text] [Related]
29. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.
Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W
Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926
[TBL] [Abstract][Full Text] [Related]
30. Decreased RNA-binding motif 5 expression is associated with tumor progression in gastric cancer.
Kobayashi T; Ishida J; Shimizu Y; Kawakami H; Suda G; Muranaka T; Komatsu Y; Asaka M; Sakamoto N
Tumour Biol; 2017 Mar; 39(3):1010428317694547. PubMed ID: 28347247
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion.
Kim M; Lee KT; Jang HR; Kim JH; Noh SM; Song KS; Cho JS; Jeong HY; Kim SY; Yoo HS; Kim YS
Mol Cancer Res; 2008 Feb; 6(2):222-30. PubMed ID: 18314483
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of expression and epigenetic profiling of TUSC1 in gastric cancer.
Kanda M; Shimizu D; Nomoto S; Hibino S; Oya H; Takami H; Kobayashi D; Yamada S; Inokawa Y; Tanaka C; Fujii T; Sugimoto H; Koike M; Fujiwara M; Kodera Y
J Surg Oncol; 2014 Aug; 110(2):136-44. PubMed ID: 24700496
[TBL] [Abstract][Full Text] [Related]
33. The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy.
Gou WF; Yang XF; Shen DF; Zhao S; Liu YP; Sun HZ; Takano Y; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19841-67. PubMed ID: 25904053
[TBL] [Abstract][Full Text] [Related]
34. Dapper homolog 1 is a novel tumor suppressor in gastric cancer through inhibiting the nuclear factor-κB signaling pathway.
Wang S; Kang W; Go MY; Tong JH; Li L; Zhang N; Tao Q; Li X; To KF; Sung JJ; Yu J
Mol Med; 2012 Dec; 18(1):1402-11. PubMed ID: 23073659
[TBL] [Abstract][Full Text] [Related]
35. Loss of Expression of Reprimo, a p53-induced Cell Cycle Arrest Gene, Correlates with Invasive Stage of Tumor Progression and p73 Expression in Gastric Cancer.
Saavedra K; Valbuena J; Olivares W; Marchant MJ; Rodríguez A; Torres-Estay V; Carrasco-Avino G; Guzmán L; Aguayo F; Roa JC; Corvalán AH
PLoS One; 2015; 10(5):e0125834. PubMed ID: 25954972
[TBL] [Abstract][Full Text] [Related]
36. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
[TBL] [Abstract][Full Text] [Related]
37. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
[TBL] [Abstract][Full Text] [Related]
38. DNA methylation of trefoil factor 1 (TFF1) is associated with the tumorigenesis of gastric carcinoma.
Feng G; Zhang Y; Yuan H; Bai R; Zheng J; Zhang J; Song M
Mol Med Rep; 2014 Jan; 9(1):109-17. PubMed ID: 24190027
[TBL] [Abstract][Full Text] [Related]
39. Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.
Gong Y; Ren J; Liu K; Tang LM
World J Gastroenterol; 2015 Mar; 21(10):2949-58. PubMed ID: 25780292
[TBL] [Abstract][Full Text] [Related]
40. The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression.
Xing YN; Yang X; Xu XY; Zheng Y; Xu HM; Takano Y; Zheng HC
Hum Pathol; 2011 Jan; 42(1):25-35. PubMed ID: 21062663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]